Reviva Pharmaceuticals Holdings's market cap is currently ―. The company's EPS TTM is $-1.69; its P/E ratio is -2.06; Reviva Pharmaceuticals Holdings is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -10.47M	$ -12.42M	$ -6.74M	$ -8.24M	$ -3.56M
EBITDA	$ -10.47M	$ -12.42M	$ -6.74M	$ -8.24M	$ -3.56M
Net Income Common Stockholders	$ -10.49M	$ -12.44M	$ 6.87M	$ -8.12M	$ -3.52M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.97M	$ 11.15M	$ 11.26M	$ 18.52M	$ 23.19M
Total Assets	$ 5.39M	$ 11.84M	$ 12.90M	$ 18.92M	$ 24.04M
Total Debt	$ 222.50K	$ 222.50K	$ 667.50K	$ 0.00	$ 0.00
Net Debt	$ -4.75M	$ -10.93M	$ -10.59M	$ -18.52M	$ -23.19M
Total Liabilities	$ 13.91M	$ 10.22M	$ 7.12M	$ 6.61M	$ 3.68M
Stockholders Equity	$ -8.52M	$ 1.62M	$ 5.78M	$ 12.32M	$ 20.36M
Cash Flow	-
Free Cash Flow	$ -6.18M	$ -5.32M	$ -7.95M	$ -4.69M	$ -4.00M
Operating Cash Flow	$ -6.18M	$ -5.32M	$ -7.95M	$ -4.69M	$ -4.00M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	$ 5.21M	$ 687.09K	$ 18.56K	$ 7.77M

Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

Income Statement >

Reviva Pharmaceuticals Holdings Debt to Assets

Balance Sheet >

Reviva Pharmaceuticals Holdings Cash Flow

Cash Flow >

Reviva Pharmaceuticals Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing